Navigation Links
Sensiotec Announces FDA 510(k) Class II Clearance for the World's First UWB Healthcare Unbound, Wireless, Non-Contact, Vital Signs and Movement Monitor
Date:2/11/2009

ATLANTA, Feb. 11 /PRNewswire/ -- Sensiotec Inc. announces FDA 510(k) Class II clearance for the world's first ultra-wideband (UWB) non-contact, continuous monitor for heart and respiration rates, bed occupancy and movement. Under the brand name Preventa(TM), Sensiotec will market and sell the medical device in the US and Canada under an exclusive worldwide license with its affiliate, Wireless 2000. Wireless 2000 received the sign off from the FDA's Division of Cardiovascular Devices.

Preventa(TM) is the first medical device to harness the potential of UWB, an emerging wireless communications standard and former classified military technology, creating a wireless vital signs monitor. In 2002, the FCC authorized the use of UWB for the development of new imaging systems to "see" inside the human body. Sensiotec CEO Robert Arkin states, "We're excited by the opportunity with Preventa(TM) to make a difference in people's lives through improved disease management while also addressing society's need to help contain runaway healthcare costs."

Preventa(TM) monitors heart and respiration rates, bed occupancy and movement on a continuous, real-time, remote basis, "watching" patients 100% of the time from a monitoring station down the hall or even 1,500 miles away. Caregivers gain a disease management tool that can help reduce complications associated with common chronic illnesses (such as heart disease, COPD and sleep apnea), optimize scarce human resources, and reduce hospital admissions and ER visits. Preventa(TM) also alerts caregivers when a patient requires an assisted relocation to help prevent bed sores. Using additional proprietary components, Preventa(TM) tracks roaming physical assets and protects wandering at-risk patients (locking exit doors or elevators automatically). Sensiotec CTO Efraim Gavrilovich states, "Wireless monitoring has great potential as an early warning system that helps to identify and manage health crises when they arise."

Company Background

Sensiotec Inc. is a development stage company based in Atlanta, Georgia. Sensiotec's value proposition is to commercialize next-generation wireless medical monitoring devices that improves healthcare quality and safety, and reduces costs. Sensiotec's strategic intent is to market Preventa(TM) in 2009.

    Media Contacts:  (404) 550-5329
    Alison Goldwater, agoldwater@sensiotec.com
    Linda Pakula, lpakula@sensiotec.com

    Corporate Contact:
    Robert Arkin: (404) 452-1891, rdarkin@sensiotec.com

'/>"/>
SOURCE Sensiotec Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... June 26, 2017 , ... Dr. Martin Bastuba, MD, ... collaboration with the Fertility Center of California, is pleased to announce the addition ... aspiration) and TESA (percutaneous testicular sperm extraction). These minimally invasive treatments are primarily ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... ... according to a recent review of government data released by the United Soybean ... in management practices, Maryland’s soybean farmers have increased their productivity on less land ...
(Date:6/26/2017)... ... June 26, 2017 , ... LARKR™ , an innovative ... in every state across the country to join its online treatment platform. , ... therapists to reach a substantially greater number of people in need nationwide, and to ...
(Date:6/26/2017)... ... 26, 2017 , ... KICKICO , a protocol built on Ethereum for ... many catastrophic issues within funding campaigns. KICKICO developers are testing the platform, which will ... the raising of funds through the power of many - has been around for ...
(Date:6/25/2017)... ... June 25, 2017 , ... FCPX LUT Vintage Volume 2 for ... look. FCPX LUT Vintage Volume 2 contains 60 different color-grade presets, giving editors multiple ... vignettes and blurs to single out subjects, plus much more. FCPX LUT Vintage Volume ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... 25, 2017  In response to the opioid epidemic ... Relief is working with Pfizer to make up to ... cost to community health centers, free and charitable clinics, ... "Pfizer has a long-standing commitment to improving ... patient safety through educational activities," said Caroline Roan ...
(Date:5/22/2017)... N.Y. , May 22, 2017  Lilac ... treatment Gene-Eden-VIR/Novirin, announces the launch of a ... English, the results of a clinical study that ... year treatment with Gene-Eden-VIR/Novirin in individuals suffering from ... to note that there are no other treatments ...
Breaking Medicine Technology: